Raloxifene
Classification: BATC code: G03XC01
Summary
As the substance is only used by women, analyses on sex or gender differences have not been considered relevant.
Additional information
Raloxifene is a selective estrogen receptor modulator (SERM). The approved indication for raloxifene is treatment of osteoporosis and osteoporosis prophylaxis in postmenopausal women [1,2].
Updated: 2016-12-23
Date of litterature search: 2016-12-20
References
- Fass.se [cited 2016-12-20]. länk
- Physicians' Desk Reference. http://www.pdr.net. [cited 2016-12-20]. länk
- Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.] Socialstyrelsens statistikdatabas
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson